Today: 3 April 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Minerva Neurosciences Stock Skyrockets on $200M Lifeline for Schizophrenia Drug

Minerva Neurosciences Stock Skyrockets on $200M Lifeline for Schizophrenia Drug

Minerva Neurosciences shares jumped over 150% on October 21, 2025, after announcing a private placement to raise up to $200 million led by Vivo Capital. The cash will fund a Phase 3 trial and FDA resubmission for its schizophrenia drug roluperidone. Trading volume surged to 39.5 million shares, and the stock hit a new 52-week high near $6.80. Market cap rose from under $20 million to about $48 million.
21 October 2025
··
iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs

iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs

iBio (NASDAQ: IBIO) traded at $0.89 midday October 21, down 63% year-to-date from $2.45 in January. Shares jumped over 20% last week after bullish “Outperform” ratings from Oppenheimer and Leerink Partners, with price targets of $5.00 and $2.00. The company reported positive preclinical results for its obesity drug IBIO-610 and raised $50 million in a recent offering. Market cap stands near $18 million.
21 October 2025
·
UnitedHealth Stock Rallies to $364 – Will UNH’s 2025 Comeback Last or Fade?

UnitedHealth Stock Rallies to $364 – Will UNH’s 2025 Comeback Last or Fade?

UnitedHealth Group shares closed at $364.48 on Oct. 21, up 2.2% on the day but still down about 30% for 2025 after plunging from an April peak near $630. The company will report Q3 earnings Oct. 28, with analysts expecting a sharp profit drop after UnitedHealth cut its full-year outlook due to surging medical costs. CEO Andrew Witty resigned in May, replaced by Stephen Hemsley.
21 October 2025
·
Equifax Stock Jumps as Earnings Beat Forecasts – Guidance Hiked, Analysts See Upside

Equifax Stock Jumps as Earnings Beat Forecasts – Guidance Hiked, Analysts See Upside

Equifax reported Q3 adjusted earnings of $2.04 per share, beating estimates, with revenue at $1.55 billion. The company raised its full-year outlook and boosted its free cash flow target. Shares traded near $231 ahead of Oct. 21, up slightly after earnings but down 15% over the past year. Equifax also unveiled a new mortgage credit score pricing strategy to undercut FICO starting in 2026.
21 October 2025
··
Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health reported Q3 2025 adjusted earnings of $6.03 per share, beating analyst estimates by over $1. Revenue reached $50.1 billion, up 12% year-over-year and ahead of forecasts. Shares jumped as much as 7% pre-market on Oct. 21 before settling near the prior close. The company reaffirmed its full-year outlook and kept costs slightly below expectations.
21 October 2025
····
Danaher (DHR) Stock Surges on Earnings Beat as Analysts Eye Upside (Oct 21, 2025)

Danaher (DHR) Stock Surges on Earnings Beat as Analysts Eye Upside (Oct 21, 2025)

Danaher reported Q3 2025 adjusted earnings of $1.89 per share on $6.05 billion revenue, beating Wall Street estimates. Shares traded near $208, up 8% in a month but still down 20% year-over-year. The company kept its full-year EPS guidance at $7.70–$7.80, slightly below consensus, sending the stock down 1% pre-market. Most analysts rate DHR a “Buy,” with an average price target of $245.
21 October 2025
··
GM Stock Skyrockets 7% as Earnings Beat, EV Strategy U-Turn Fuel Rally

GM Stock Skyrockets 7% as Earnings Beat, EV Strategy U-Turn Fuel Rally

General Motors shares jumped 6–7% to over $61 on October 21 after Q3 earnings and revenue beat estimates and the company raised its 2025 profit outlook. Adjusted EPS reached $2.80, topping forecasts, while revenue hit $48.6 billion. GM also announced a slowdown in its EV rollout, taking a $1.59 billion charge tied to strategic changes. Wall Street sentiment turned more positive, with several analysts raising price targets.
21 October 2025
··
3M Stock Set to Soar! PFAS Settlement and Dividends Spark Rally (Oct 2025)

3M Stock Soars on Earnings Beat & Turnaround Progress – What Investors Need to Know

3M shares closed at $154.78 on Oct. 20, up 17.5% year-on-year, after Q3 earnings beat estimates and the company raised full-year guidance. The firm reported adjusted EPS of $2.19 on $6.3 billion revenue and now expects 2025 EPS of $7.95–$8.05. Legal liabilities from PFAS and earplug lawsuits persist, with a key PFAS trial set for late October. Analyst sentiment has improved, with price targets rising to as high as $185.
21 October 2025
··
IDFC First Bank Stock Soars 7% After Profit Surge – What’s Next for its Share Price?

IDFC First Bank Stock Soars 7% After Profit Surge – What’s Next for its Share Price?

IDFC First Bank shares jumped nearly 7% to ₹77 on October 20, 2025, after Q2 FY26 net profit rose 75.5% year-on-year to ₹352.3 crore. Net interest income increased 6.8% to ₹5,113 crore, while gross NPAs held at 1.86%. Brokerages raised price targets, with Jefferies moving to ₹85. CEO V. Vaidyanathan said asset quality remains steady and expects further improvement in funding costs.
21 October 2025
·
ICICI Bank Stock at ₹1,380 Today – Analysts Eye ₹1,800 Target After Q2 Earnings Shock

ICICI Bank Stock at ₹1,380 Today – Analysts Eye ₹1,800 Target After Q2 Earnings Shock

ICICI Bank shares traded near ₹1,380 on October 21, down 0.5% after a 3% drop post-earnings. Q2 net profit rose 5% year-on-year to ₹12,359 crore, but moderated loan growth and a slight uptick in gross NPA weighed on sentiment. The stock remains up about 8.5% year-to-date, outperforming broader indices. Analyst targets range from ₹1,680 to ₹1,800, citing strong margins and asset quality.
21 October 2025
·
South Indian Bank Stock Soars to Record High on Q2 Earnings – Will ₹50 Be Next?

South Indian Bank Stock Soars to Record High on Q2 Earnings – Will ₹50 Be Next?

South Indian Bank shares hit a record ₹38.44 on October 21, 2025, after strong Q2 earnings and a surge in trading volumes. Net profit rose 8.2% to ₹351.6 crore, while gross NPA fell to 2.93%. High-net-worth investor Aditya Kumar Halwasiya bought a 0.76% stake during the rally. Brokerages raised targets to ₹42, citing improved fundamentals and steady loan growth.
21 October 2025
··
RRP Semiconductor Stock Skyrockets 57,000%; Sachin Tendulkar Link Debunked

Mystery Chip Stock Soars ~57,000% to ₹9,500 – RRP Semiconductor’s Frenzy Triggers Bubble Fears

RRP Semiconductor Ltd shares soared from ₹15 in April 2024 to ₹9,478 on October 21, 2025, locking at the 2% upper circuit. The Bombay Stock Exchange imposed strict trading curbs, citing a price rise “not commensurate with the financials.” RRP denied rumors linking it to Sachin Tendulkar or government land. The company reported only a few crores in profit and has just two employees.
21 October 2025
··
Duralex Crisis Deepens: Iconic French Glassmaker Seeks €5M Lifeline from Public Investors

Duralex Crisis Deepens: Iconic French Glassmaker Seeks €5M Lifeline from Public Investors

Duralex, saved by its workers in 2024, remains financially unstable, with 2025 sales projected below the €35 million break-even point. The glassmaker launched a €5 million public crowdfunding campaign, offering 8% returns, to fund new products and factory upgrades. Director General François Marciano says banks remain cautious until results improve. Employees have cut costs and rotated store shifts to avoid new hires.
21 October 2025
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 21.10.2025

Weatherford International reported Q3 earnings of $81 million, or $1.12 per share, missing analyst estimates and down from $157 million a year earlier. Revenue dropped 12.6% to $1.232 billion. U.S. stocks ended mixed as the Dow rose 0.5%, the S&P 500 was flat, and the Nasdaq slipped. General Motors raised its forecast, while Netflix fell after missing targets.
21 October 2025
·
Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple Stock Soars to Record High on iPhone 17 “Supercycle” Buzz – Will the Rally Last?

Apple stock closed at a record $262.24 on Oct. 20, up nearly 4% after iPhone 17 sales jumped 14% over last year’s launch in the U.S. and China. Loop Capital and Evercore ISI raised ratings and targets, but Jefferies downgraded the stock, citing high expectations. Apple neared a $4 trillion valuation. Earnings are due Oct. 30, with analysts expecting $101 billion in revenue.
20 October 2025
··
Beam Therapeutics Stock Soars on Gene-Editing Buzz – Analysts Project Big Upside

Beam Therapeutics Stock Soars on Gene-Editing Buzz – Analysts Project Big Upside

Beam Therapeutics shares jumped 17% to $30.35 on Oct. 20, 2025, marking their highest level since early 2024. The rally followed bullish technical signals and positive clinical updates for its gene-editing therapies. Analysts at Jefferies and H.C. Wainwright reiterated Buy ratings, with price targets up to $80. Beam ended Q2 with $1.2 billion in cash, enough to fund operations into 2028.
20 October 2025
·····
Celcuity Stock Skyrockets 40% to Record High on ‘Practice-Changing’ Cancer Trial Results

Celcuity Stock Skyrockets 40% to Record High on ‘Practice-Changing’ Cancer Trial Results

Celcuity shares jumped over 40% Monday to a record near $80 after Phase 3 trial data showed its drug gedatolisib cut risk of progression or death by 76% in advanced HR+/HER2- breast cancer. The company confirmed full enrollment of the PIK3CA-mutant cohort, with final results expected by mid-2026. Needham raised its price target to $95. Celcuity’s market cap topped $2.2 billion.
20 October 2025
··
Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Salesforce Stock Surges After $60B AI Bombshell – Here’s What’s Next (Oct 20, 2025)

Salesforce shares surged nearly 7% to $253 on Thursday, Oct. 16, 2025, after unveiling new long-term revenue targets and AI plans at Dreamforce. The stock eased to close Friday near $243 and traded in the mid-$240s Monday. Year-to-date, CRM is down about 27–28%. Wall Street analysts remain mostly bullish, with average price targets around $330.
20 October 2025
····
GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

GRAIL Stock Rockets on Samsung Mega-Deal and Cancer Test Breakthrough

GRAIL shares surged 14% to a record $85.35 on Oct. 16 after Samsung agreed to invest $110 million and partner on cancer test rollout in Asia. New trial data showed Galleri’s blood test boosted early cancer detection seven-fold in a 25,000-patient study. GRAIL secured $325 million in fresh funding, extending its cash runway into 2030. Analysts remain cautious, with a consensus Hold rating and a $57 price target.
20 October 2025
···
1 … 224 225 226 227 228 … 361

Stock Market Today

  • Wall Street Analysts See 181% Upside Potential in Spruce Biosciences (SPRB) Shares
    April 3, 2026, 11:48 AM EDT. Spruce Biosciences (SPRB) closed at $70.50, up 31.1% in four weeks. Wall Street analysts set a mean price target of $198.25, implying an 181.2% upside. Targets range from $140 to $283, highlighting variation among analysts. A low standard deviation suggests strong agreement on direction. Analysts also expect earnings to surpass prior estimates, reinforcing bullish sentiment. However, researchers warn price targets may be overly optimistic due to potential conflicts of interest for analysts. Price targets alone shouldn't drive investments but can prompt further fundamental analysis. Investors should consider consensus views alongside other market signals before trading SPRB shares.
Go toTop